By rray, 12 July, 2024 If pt empties well after 1st BTX injection may check PVR post procedure for subsequent injections retention after hx of good emptying is rare
By rray, 12 July, 2024 If acute UTI treat based on AUA CUA SUFU Recurrent Uncomplicated UTIs in Women guideline
By rray, 12 July, 2024 If PVR uarr w respect to voided volume i e PVR 100 300 mL may start CIC based on voiding emptying sx or UTI presence
By rray, 12 July, 2024 Obtain PVR and UA cx UTI or incomplete emptying may be the reason for lack of sx improvement
By rray, 12 July, 2024 Evaluate pt 2wk after initial BTX injection Chance of UTI is highest 2wk post procedure
By rray, 12 July, 2024 If inadequate response to or intolerable side effects from pharmacotherapy or behavioral tx offer 1 of the following MR A
By rray, 12 July, 2024 Intradetrusor botulinum toxin BTX injection nbsp nbsp 100U intradetrusor BTX injection improves OAB sx in male and female pts w inadequate response to or who ve experienced intolerable side effects from antimuscarinics and or 3 agonists nbsp nbsp Low side
By rray, 12 July, 2024 Percutaneous tibial nerve stimulation PTNS nbsp nbsp darr of 2 voids day 1 2 nocturia episodes and 1 2 urinary incontinence episodes day vs baseline
By rray, 12 July, 2024 Sacral neuromodulation SNM nbsp nbsp Adverse events surgical revision for pain or infection device discomfort lead migration nbsp nbsp Assoc w high immediate and long term success rates 50 improvement in both BTX na ve pts and in those w an inadequate res
By rray, 12 July, 2024 If inadequate improvement w a single medication May offer combo tx w a medication from a different class e g antimuscarinic 3 agonist CR B